Table 2.
Levels of IL-17 and TGF-β1 and percentages of Th17 and Treg in DHLI, SKYD, and healthy control groups (mean ± SD) *.
| DHLI | SKYD | Healthy control | |
|---|---|---|---|
| Serum level (pg/mL) | |||
| IL-17 | 26.58 ± 8.19#△ | 19.09 ± 6.90# | 13.46 ± 1.77 |
| TGF-β1 | 31.53 ± 9.04#△ | 29.80 ± 8.79# | 37.01 ± 8.11 |
|
| |||
| Expression level in colonic mucosa (OD value) | |||
| IL-17 | 0.28 ± 0.11#△ | 0.23 ± 0.09# | 0.09 ± 0.02 |
| TGF-β1 | 0.0052 ± 0.0013#△ | 0.0045 ± 0.0008# | 0.0025 ± 0.0005 |
|
| |||
| Percentages of Th17 and Treg in peripheral blood (%) | |||
| Th17 | 3.1 ± 0.8#△ | 2.6 ± 0.7# | 0.1 ± 0.0 |
| Treg | 7.8 ± 1.1#△ | 4.8 ± 0.9# | 10.8 ± 0.2 |
*indicated P < 0.05 comparing with control group; △represented P < 0.05 comparing with SKYD group.